Dulaglutide
Dulaglutide is a pharmaceutical drug with 73 clinical trials. Currently 10 active trials ongoing. Historical success rate of 96.4%.
Success Metrics
Based on 54 completed trials
Phase Distribution
Phase Distribution
14
Early Stage
13
Mid Stage
37
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
96.4%
54 of 56 finished
3.6%
2 ended early
10
trials recruiting
73
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
Clinical Trials (73)
Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)
Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.
Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus
Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis
Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data
Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
A Study of HS-20094 in Patients With T2DM
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India
Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 73